The chemotherapeutic value of methotrexate resides in its ability to perturb folate-dependent one-carbon metabolism and subsequently inhibit DNA synthesis. To assess the functional effect of methotrexate on hepatic one-carbon metabolism, we have developed and applied tracer kinetic techniques in vivo to quantify the carbon flux through the folate-dependent one-carbon pool in rats. Following a 7-day treatment period with methotrexate (0.2 mg/kg body weight), the tracers L-[ring-2-l4 C] histidine and L-[methyl-3 H] methionine were simultaneously infused into control and methotrexate-treated rats. Methotrexate treatment decreased hepatic tetrahydrofolate, methyltetrahydrofolate, and formyltetrahydrofolate concentrations by 63, 83, and 58%, respectively. Furthermore, the enzymatic activity of 10-formyltetrahydrofolate dehydrogenase, the terminal enzyme in the catabolism of the ring-2-carbon of histidine to CO 2 , was diminished by 32% in methotrexate-treated animals. These changes in enzyme activity and folate coenzyme concentrations did not result in a significant decrease in the oxidative flow of carbon from histidine to CO 2 in methotrexate-treated rats compared to control animals (2.40 and 3.22 ujnol/h/kg 3/4 , respectively). Oxidative carbon flow was reflective of tetrahydrofolate and formyltetrahydrofolate pools when expressed as a percent of total folate: neither coenzyme pool was diminished as a result of methotrexate treatment In contrast, the reductive carbon flux through the one-carbon pool from histidine to methionine was significantly decreased 59% in methotrexate-treated (7.63 nmol/h/kg" 4 ) versus control rats (18.73 nmol/(h/kg 3 ' 4 )). Likewise, methyltetrahydrofolate, as a percent of total folate, was reduced 51% in methotrexatetreated rats. Consequently, total measured carbon flow (oxidative + reductive) was 54% lower in rats subjected to subchronic methotrexate treatment These tracer kinetic experiments quantitatively demonstrate the extent to which methotrexate alters the actual carbon flow through the hepatic folate-dependent one-carbon pool, primarily directed at diminishing the reductive carbon flow towards methyltetrahydrofolate and methionine synthesis.
Introduction
Folate-dependent one-carbon metabolism is important in the biosynthesis of a number of molecules essential for growth and proliferation such as DNA and methionine. The pyrimidine thymidylate is synthesized from the methylation of uridylate with the one-carbon unit donated by the tetrahydrofolate
•Abbreviations: THF, tetrahydrofolate; MTX, methotrexate; DHF, dihydrofolate.
(THF*) coenzyme 5,10-methylene-THF, whereas the carbon-2 and -8 positions of the purine ring are derived from carbon units supplied by 10-forrnyl-THF. In addition, the methyl group from 5-methyl-THF is utilized to remethylate homocysteine for de novo methionine synthesis. Hence, the basis for utilizing folate antagonists in chemotherapy residues in their ability to impair one-carbon metabolism and subsequently inhibit cellular proliferation.
One of the most widely used chemotherapeutic agents is methotrexate (MTX), a folate analog which competitively inhibits the one-carbon pool enzyme dihydrofolate (DHF) reductase (1-3). DHF can be generated from 5,10-methylene-THF as a result of thymidylate synthesis or from the NADPHdependent reduction of folic acid (Figure 1 ). In turn, DHF must be reduced by DHF reductase to THF in order to actively participate as a coenzyme in the one-carbon pool. The inhibition of DHF reductase by MTX results in an intracellular depletion of fully reduced folate coenzyme (4) (5) (6) (7) (8) (9) (10) (11) and a perturbation of one-carbon metabolism, including DNA synthesis and cellular proliferation. However, a number of reports (4, (6) (7) (8) 12) indicate that the concentration of folate coenzymes as well as the enzymatic activity of DHF reductase remain present in significant quantities even after MTX administration. Therefore, it is important to examine the ability of MTX to perturb onecarbon metabolism on a functional basis by quantifying changes in the actual flow of carbon through the one-carbon pool.
We have developed in vivo tracer kinetic techniques to examine hepatic folate-dependent one-carbon metabolism in rats (13) (14) (15) . These methods provide a quantitative determination of the actual carbon flow through the one-carbon pool under a variety of both physiological and pathophysiological conditions. The studies presented here have extended these tracer kinetic techniques by utilizing radiolabeled histidine and methionine simultaneously to determine both the oxidative and reductive carbon flux through the one-carbon pool to CO 2 and methionine, respectively, in rats treated with MTX.
Materials and methods

Animals and diets
All experiments involving animals were approved by and conducted in accordance with guidelines established by the University of Wisconsin Research Animal Resources Committee. Male Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, IN) were housed in suspended wire-mesh cages in a room with a 12-h light-dark cycle. All rats were fed an 18% casein diet ad libitum throughout the study (Table I) . Rats were anesthetized with sodium pentobarbital (75 mg/kg body weight) and a polyethylene cannula was inserted into the duodenum. Following a 9-day recovery period, MTX rats were injected i.p. with 0.2 mg MTX/kg body weight daily approximately 8 h into the light cycle for a total of 7 days. Control animals were vehicleinjected with saline. Tracer kinetic experiments were performed 3-4 h into the light cycle on the eighth day.
Infusion experiments
Following the 7-day treatment period, rats were placed in metabolic chambers and continuously infused with L-[ring- 2-l4 (5) 5-formimino-THF deaminase to yield 5,10-methenyl-THF. The one-carbon moiety of 5,10-methenyl-THF can proceed oxidatively through the one-carbon pool to 10-fonnyl-THF, where the formyl group can be released as CO2, a reaction catalyzed by the key enzyme (6) 10-formyl-THF-dehydrogenase, or it can be utilized for purine synthesis. The majority of one-carbon units for the one-carbon pool originate from the 3-carbon of serine in a reaction catalyzed by (8) serine hydroxymethyltransferase. In the reductive direction, the one-carbon group of 5,10-methenyl-THF can be reduced to the formaldehyde oxidation state as 5,10-methylene-THF, and further reduced to the methanol oxidation state as 5-methyl-THF, a physiologically irreversible reaction (9) catalyzed by the key enzyme 5,10-methylene-THF reductase. In order to regenerate THF, the carbon group of 5-methyl-THF is utilized to remethylate homocysteine and yield methionine, a B 12 -dependent reaction catalyzed by (10) methionine synthase. In turn, methionine can be activated by (11) methionine adenosyltransferase to S-adenosylmethionine (SAM), the labile methyl group donor in a number of biological methylation reactions. Following SAM-dependent transmethylation (12), the product S-adenosylhomocysteine (SAH) is metabolized by (13) SAH hydrolase to adenosine (Ado) and homocysteine, which can proceed through the trans-sulfuration pathway to cysteine and taurine, or be remethylated to methionine. 5,10-Methylene-THF can also serve as the carbon donor for thymidylate synthesis, a reaction which yields dihydrofolate (DHF). DHF must be reduced by (7) DHF reductase in order to regenerate THF for subsequent folate-dependent one-carbon metabolism to function properly.
pulled through the chamber at approximately 400 cc/min and expired CO? was continuously trapped in 2 N NaOH at 15 min intervals throughout the infusion period. After 250-280 min of total infusion time, rats were sacrificed by decapitation and liver samples were taken for subsequent metabolite and enzyme activity analysis. As shown in Figure 2 and in previous work (13) (14) (15) , utilization of these infusion rates and time periods ensured that a plateau (i.e. steady state) in the specific activity of hepatic histidine, methionine, and expired CO2 was achieved.
Histidine and methionine analysis
The procedure we have developed for the assessment of the specific activity of hepatic methionine (13) and histidine (15) was utilized in these studies with a few modifications. Liver samples were homogenized in 4 vol of 2 N perchloric acid and centrifuged at 10 OOOXg for 10 min. A 3.0 ml sample of the resulting supernatant was placed on a 3.0X1.0 cm column of Dowex 50W-X12 cation-exchange resin and the amino acids were eluted with 20 ml of 1 N NH4OH and dried in vacua. Dried amino acid samples were reconstituted in 1.0 ml of 40 mM lithium carbonate (pH 9.5) buffer and derivatized with 1.0 ml of 20 mM dimethylaminonaphthalenesulfonyl (dansyl) chloride (16) for subsequent HPLC analysis. The isocratic separation and quantification of dansyl-methionine was accomplished using a mobile phase consisting of 22% acetonitrile in 10 mM sodium acetate-0.2% phosphoric 
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E (dp In panel A, each point represents an independent infusion experiment, whereas expired CO2 (panel B and C) was collected throughout the infusion period (280 min) from an individual rat. The plateau SA of COj (panel B) was estimated using non-linear regression (SAS). Linear regression analysis was employed to calculate the total CO2 expiration rate (panel C) and used as an estimate of the irreversible loss rate of expired CO2. acid (pH 3.50) in conjunction with UV detection at 254 nm. Dansyl-histidine was quantified using the same HPLC system employing a 16% acetonitrile mobile phase operated isocratically at a flow rate of 1.0 ml/min. Peak dansylmethionine and dansyl-histidine fractions were collected for the assessment of both 3 H-and 14 C-radioactivity by liquid scintillation counting.
Expired CO2 specific activity Aliquots were taken from each 15 ml (15 min) NaOH-trap solution and utilized for the measurement of the specific activity of expired CO2. Radioactivity was assessed by liquid scintillation counting of a 0.5 ml NaOH sample mixed with 1.0 ml of methyl cellusolve and 18 ml of Opti-fluor (Packard Instrument Co., Inc., Downers Grove, IL). In a separate 1.0 ml sample of each NaOHtrap solution, expired CO 2 was precipitated as BaCO3, dried, and weighed (17) . All necessary precautions were taken to insure that chemiluminescence due to NaOH did not contribute significantly to CO2 radioactivity measurements. In addition, a number of BaCO 3 samples were acidified in a sealed vial and the released radiolabeled CO 2 was trapped in ethanolamine and subjected to liquid scintillation counting for further verification of CO 2 specific activity. (19, 20) . Formiminoglutamate (FiGlu) formiminotransferase (EC 2.1.2.5) activity was measured by monitoring the production of 5,10-methenyl-THF at 350 nm (21) . The enzymatic activities of 10-formyl-THF hydrolase and 10-formyl-THF dehydrogenase (EC 1.5.1.6) were determined spectrophotometncally at 300 nm according to the method described by Case et at. (22) . Trie enzyme activity of 5,10-methylene-THF reductase (EC 1.5.1.20) was isotopically assayed by determining the amount of 14 C-formaldehyde generated from 5-' 4 CH 3 -THF (23, 24) .
Enzyme measurements
Metabolite measurements
The hepatic concentrations of THF, methyl-THF, and formyl-THF were measured according to the method of Case and Steele (25) with a few modifications. Briefly, liver samples homogenized in 4 vol of 0.1 M sodium acetate (pH 4.9)-0.5% ascorbate-20 mM 2-mercaptoethanol buffer were placed in a boiling water bath for 60 min followed by centnfugation at 40 OOOXg for 30 min. The resulting supernatant was incubated with 0.3 ml crude hog kidney conjugase at 37°C for 60 min, filtered through a Centriprep-30 ultrafiltration unit (Amicon, Danvers, MA), and placed on a 3.0X0.5 cm column of DEAE-Sephadex A-25 (Pharmacia, Piscataway, NJ) anion-exchange resin equilibrated with 0.1 M sodium acetate (pH 4.9) buffer. After elution with 0.2 M sodium acetate (pH 4.9)-1 M sodium sulfate-1% ascorbate buffer, the folate coenzymes were separated by reversed-phase HPLC on a HBondapak™ Phenyl Radial-PAK™ column (Waters Associates, Milford, MA) and quantified using a Waters 991 photodiode array detector (Waters Associates, Milford, MA). This procedure was also utilized for the assessment of hepatic methotrexate concentrations. S-Adenosylmethionine (SAM) and S-adenosylhoraocysteine (SAH) were isolated and quantified with a few modifications of the HPLC procedure described by Fell et al. (26) . A 2.0 ml sample of the 2 N perchloric acidsupematant utilized for the quantification of hepatic methionine and histidine was neutralized with 8 N KOH and applied to a methanol-charged C|g SepPak® cartridge (Waters Associates, Milford, MA). SAM and SAH were sequentially eluted with 1.2 ml of 0.175 M acetic acid and 7.0 ml of 25% methanol in 0.175 M of acetic acid followed by quantification on a reversedphase HPLC system consisting of a (iBondapak™ C 18 Radial-PAK™ column in conjunction with UV detection (254 nm) and an isocratic mobile phase containing 20% methanol in 5 mM octane sulfonic acid (pH 4.0) operated at a flow rate of 1.2 ml/min. Peak SAM fractions were collected and subjected to dual isotope ( 
Calculations
An extensive text on the theory and use of in vivo tracer kinetic techniques has been published (27) . The specific tracer kinetic measurements and calculations we employed in these studies were an extension of those described previously (13) (14) (15) . Briefly, once a plateau (i.e. steady-state) in the specific activity (SA; 14 C-dpm/|imol) of hepatic histidine and expired CO2 had been achieved (Fig. 2) , the following calculation was made:
where the ILR Hlj and the IRH,, were the irreversible loss rate and infusion rate of histidine, respectively. In addition, the often existed in accurately assessing the I4 C-SA MH . Alternatively, the 14 C-SAJAM was measured and equated with the 14 C-SA Mn since the only source of SAM is from the activation of methionine. Theoretically, the SAJAM ' S m equilibrium with the SAM« under steady-state conditions and consequently, the percentage of total entry into the SAM pool that is originating from methionine (i.e. TQSAMJUC) equals 100. Thus, the transfer quotient to methionine from histidine was calculated as:
Finally, the oxidative carbon flux (F) from histidine through the one-carbon pool to CO2 was calculated as:
where the ILRCCH was estimated from the total CO2 expiration rate (Fig. 2) . Similarly, the reductive flow of carbon from histidine to methionine was calculated as:
Statistical analysis
Mean values across treatment groups were compared using a one-tailed Student's /-test at a significance level of 5% (28) .
Results
Growth of rats
Control and MTX-treated rats exhibited similar growth rates during the 7 day treatment period: final body weights were not significantly different (263 ± 5 and 268 ± 6 g for control and MTX rats, respectively). In a parallel study, rats fed 0.1 mg MTX/kg body weight for 14 days did not demonstrate any difference in growth compared with control animals, whereas rats fed 0.5 mg MTX/kg body weight had marked depressions in growth and in some cases died due to mucosal hemorrhaging after only 10 days of MTX treatment (Case.G.L. and Steele.R.D., unpublished observation). It has been reported that rats can tolerate 0.1 mg MTX/kg body weight for up to 4 months without affecting their growth rate or exhibiting severe side-effects (5,29). As evidenced by the normal growth rate exhibited by MTX rats, the dose and length of treatment period with MTX were quite mild. Mean (±SEM) hepatic MTX concentrations were 0.28 ± 0.07 nmol/g liver. This represents approximately 30% of the daily injected dose when expressed as the total amount of MTX in the liver.
Activities of enzymes involved in histidine degradation and one-carbon metabolism
The effect of MTX administration on the activity of enzymes involved in histidine and one-carbon metabolism is shown in Table II . No difference was seen in the activities of the histidine-degrading enzymes histidase, urocanase, and FiGlu "Data are means ± SEM, n = 4. "The ratio of SAM (nmol/g liver) to SAH (nmol/g liver).
formiminotransferase. Likewise, the activities of 10-formyl-THF hydrolase and 5,10-methylene-THF reductase were unaffected by MTX treatment. The latter enzyme is a key enzyme in one-carbon metabolism since it irreversibly reduces the one-carbon unit to the methanol oxidation state as 5-methyl-THF. Consequently, the methyl group must be utilized to remethylate homocysteine and yield methionine in order to regenerate THF. MTX-treated rats did exhibit a 32% reduction in the enzymatic activity of 10-formyl-THF dehydrogenase, the key terminal enzyme involved in the oxidation of THFbound one-carbon groups to CO 2 (e.g. catabolism of the ring-2-carbon of histidine).
Hepatic metabolite concentrations
Although MTX-rats exhibited normal growth and no visible side-effects, this protocol for MTX administration was sufficient to effectively perturb folate coenzyme pools. The hepatic concentration of all of the folate coenzymes measured were markedly reduced in rats receiving MTX (Table III) . THF, methyl-THF, and formyl-THF concentrations were decreased 63, 83, and 58%, respectively, compared to control values. Collectively, this resulted in a 70% depletion of total folate coenzymes in the livers of MTX-treated rats. When expressed as a percentage of total folate concentration, methyl-THF pools decreased 51%, whereas THF and formyl-THF pools were not significantly altered by MTX treatment. Administration of MTX did not effect the concentration of a number of other metabolites related to one-carbon metabolism. The hepatic concentrations of SAM, SAH, and the ratio of SAM/SAH were the same in control and MTX-treated rats (Table IV) . Likewise, MTX treatment did not alter the hepatic concentrations of histidine and methionine (Table IV) . 
Tracer kinetic assessment of carbon flux
In contrast to metabolite concentration and enzymatic activity measurements presented above, the dynamic assessment of one-carbon metabolism via tracer kinetic techniques provides a functional evaluation of the ability of MTX to perturb the one-carbon pool. The kinetic assessment of hepatic histidine, methionine, and expired CO2 pools is shown in Table V . Although the irreversible loss rate (ILR) of histidine and expired CO 2 were unchanged between treatment groups, the administration of MTX reduced the ILR Met 39% compared to control values. The effect of MTX administration on the actual carbon flow through the one-carbon pool, in both the oxidative and reductive direction, is shown in Table VI . Although the oxidative flux of carbon from histidine to CO 2 was 25% lower in MTX rats, this change was not found to be statistically significant. MTX rats did exhibit a pronounced decrease (59%) in the reductive flow of carbon from histidine to methionine. Consequently, the total (i.e. reductive + oxidative) carbon flux measured in MTX-treated rats was less than half the value exhibited by control animals.
Discussion
Tracer kinetic techniques with radiolabeled histidine and methionine were utilized to evaluate the physiological importance of methotrexate on folate-dependent one-carbon metabolism. These methods provide for the first time quantita-tive data evaluating the carbon flow through the hepatic folatedependent one-carbon pool in control and methotrexate-treated rats. Methotrexate administration markedly diminished reduced-carbon folate coenzyme pools and subsequently perturbed the reductive flow of carbon through the one-carbon pool. Although the carbon flux to thymidylate was not directly measured, the inhibition of DNA synthesis as the basis for the chemotherapeutic value of methotrexate is supported by the significant decrease we found in the reductive flow of carbon to methionine (Table VI) . Consistent with these measurements, MTX administration has been shown by us and others to decrease the concentration of 5-methyl-THF (4,5,10,30) and 5,10-methylene-THF (9) even though the activity of 5,10-methylene-THF reductase was unchanged. A diminished ability to remethylate homocysteine is also supported by a MTX-induced decrease in the concentration of betaine and methionine (29) .
The decrease in carbon flux in these studies (Table V) was due primarily to a reduction in the irreversible loss rate of methionine (Flux MetHls = ILR Met XTQ MetiHls ). Since the growth of MTX rats was the same as control animals (Table II) , methionine utilized for protein synthesis was presumably unaffected. The decrease in the ILR Met could be the result of a reduction in the rate at which the methyl carbon of methionine was activated to SAM and used for transmethylation reactions. Although previous reports found a decrease in the concentration of SAM due to MTX treatment (30, 31) , the hepatic concentrations of SAM and methionine measured in our studies were not diminished as a result of MTX treatment (Table TV) . However, the mean values for both of these compounds were substantially lower than the average values reported in the literature. In these infusion experiments, rats were sacrificed 8 h into the light cycle and consequently the low concentration of methionine, SAM, and the ratio of SAM/SAH may be attributed to food availability and diurnal variation (31) , thereby compromising the ability to detect MTX-mediated changes in these metabolites.
MTX treatment did not alter the activity of 5,10-methylene-THF reductase (Table II) , the enzyme which irreversibly catalyzes the reduction of the methylene group of 5,10-methylene-THF to the methanol oxidation state as 5-methyl-THF. Since DHF inhibits 5,10-methylene-THF reductase activity (33) , this finding suggests that the accumulation of DHF does not appear to be significant. Likewise, in vitro studies have demonstrated that DHF concentrations were only elevated 27% following MTX treatment (11) . However, it is important to note that the in vitro conditions utilized to assess 5,10-methylene-THF reductase activity probably do not reflect in vivo regulation of the enzymatic activity. The TQmohyi-THF.His suggests that a greater percentage of the total entry into the 5-methyl-THF pool originated from histidine in MTX-treated rats compared to controls (32.5 ± 2.7 and 24.5 ± 1.7%, respectively). Assuming that the MTX-mediated reduction of carbon flow to methionine is also true for the carbon flow to 5-methyl-THF, the ILRn^^i.THF must be markedly diminished as a result of MTX treatment. An 83% decrease in the concentration of 5-methyl-THF supports this possibility (Table m) .
In contrast to the reductive carbon flux, the oxidative flow of carbon from histidine to CO 2 was not altered in MTX rats (Table VI) even though a decrease in both the concentration of formyl-THF (Table HI) and the enzymatic activity of 10-formyl-THF dehydrogenase (Table II) would suggest otherwise.
It should be noted that the method employed in these studies to measure folate coenzymes does not differentiate between 10-formyl-THF and 5-formyl-THF, hence the basis for referring to this measurement as formyl-THF. Although the concentration of 5-formyl-THF typically constitutes a small percentage of total folate pools (34), recent evidence suggests that it may play an important physiological role in the regulation of folatedependent one-carbon metabolism (35) . A number of reports have shown a decrease in 10-formyl-THF levels due to MTX treatment of cultured cells (9, 10) . In addition, the decrease in the concentration of THF (Table ni) indicates that the ability of the n>jg-2-carbon of histidine, as the formimino group of FiGlu, to enter the one-carbon pool may be limited. However, in support of the actual carbon flow data, the enzymatic activity of FiGlu formiminotransferase as well as the other histidinedegrading enzymes (Table II) and the concentration of hepatic histidine (Table IV) were not affected by MTX. Likewise, when expressed as a percentage of total folate, both THF and formyl-THF were unaffected by MTX treatment, in contrast to the marked depletion of 5-methyl-THF pools. Although not statistically significant, there was a trend in MTX-treated rats for the percentage of total folate as formyl-THF to increase at the expense of 5-methyl-THF. Clearly, the absolute concentrations of all folate coenzymes were markedly diminished due to MTX treatment. However, it is important to also examine the data as relative concentrations (i.e., percent total folate), especially since a shift from reduced-carbon folate coenzymes to oxidized-carbon forms has been reported in previous in vivo studies using a similar MTX administration protocol (30) . Thus, our kinetic measurements of actual carbon flow appear to reflect the relative distribution of total folate between oxidized-carbon and reduced-carbon forms, rather than the absolute concentration of specific folate coenzyme pools.
Recently, compartmentation of folates has been recognized as an important aspect of one-carbon metabolism (36) . A number of compounds known to perturb one-carbon metabolism, including methotrexate, exert their effects on cytosolic folates, whereas mitochondrial folates remain relatively stable (10, 34, 37) . In a parallel study with various levels of MTX, we have also noted that cytosolic folate coenzyme pools were depleted more rapidly and to a greater degree than mitochondrial folates (Case.G.L. and Steele,R.D., unpublished observation). Consequently, the effects of MTX on carbon flux as described here may be even more pronounced if subcellular compartmentation is taken into consideration.
The use of tracer kinetic techniques is a valuable tool to assess the physiological importance of a given treatment and its ability to perturb a metabolic pathway. In contrast to single static measurements, a dynamic kinetic assessment reflects the metabolic system as a whole. The administration of MTX in our studies found that the concentration of many metabolites and enzyme activities did correlate with actual changes in the reductive flux of carbon, however, this relationship was not evident with respect to the oxidative carbon flow. Further utilization of these techniques may provide insight into the potential mechanisms underlying the action of MTX, especially in view of the more recent literature. Evidence has been reported to suggest that the ability of MTX to inhibit nucleotide synthesis is not strictly the result of DHF reductase inhibition and a depletion of cellular folate pools. A number of investigators have found that persistent levels of folate coenzymes remained following MTX treatment, even though DHF reduc-tase activity was almost completely abolished (4, (6) (7) (8) 12) . This has led to the use of computer simulation to examine the effects of MTX on enzyme activities and folate coenzyme concentrations (11) . Consequently, it was postulated that either methotrexate or DHF may directly inhibit enzymes involved in nucleotide synthesis. As we have demonstrated here, the utilization of tracer kinetic techniques is a unique and valuable approach to further assess the kinetic changes induced by MTX treatment on one-carbon metabolism directly. In agreement with Selhub et al. (30) , the ability of methotrexate to perturb one-carbon metabolism, as presented here on a kinetic basis, appears to be directed at diminishing the reductive carbon flow towards 5-methyl-THF and methionine synthesis.
